Oxford Biodynamics PLC (LON:OBD), a biotechnology company focused on the discovery and development of epigenetic biomarkers based on regulatory genome architecture, for use within the pharmaceutical and biotechnology industry, today announced
Reading your genome is becoming ever easier and cheaper. That makes it possible to figure out which medicines are more likely to work for you. Dr Mike Tubbs looks at
A study using Oxford BioDynamics’ EpiSwitch showed the blood test that looks for epigenetic biomarkers can help identify an inadequate response to using methotrexate (MTX) in treating early rheumatoid arthritis.
Taking common painkillers including paracetamol during pregnancy could make their grandchildren infertile, research suggests. Previous studies have found that the drug ibuprofen could harm the fertility of girls. Women are advised
Oxford Biodynamics’ Dr Ewan Hunter discusses the recent published study in the Journal of Translational Medicine in this exclusive interview with DirectorsTalk
Recent studies have highlighted super-enhancers (SEs) as important regulatory elements for gene expression, but their intrinsic properties remain incompletely characterized. Through an integrative analysis of Hi-C and ChIP-seq data, here
There is a good understanding of the functional impact of protein-coding variants owing to historical studies of Mendelian disorders, the predictable consequences of amino acid changes and the recent availability
Oxford Biodynamics Plc (LON:OBD) Director of Business Development & Head of Statistics Dr. Ewan Hunter talks to DirectorsTalk about the publication of a paper in the Journal of Translational Medicine.
Oxford BioDynamics Plc (LON:OBD), a biotechnology company focused on the discovery and development of epigenetic biomarkers based on regulatory genome architecture, for use within the pharmaceutical and biotechnology industry, is pleased
Oxford Biodynamics’ Dr Alexandre Akoulitchev discusses their latest ALS biomarker data in this exclusive interview with DirectorsTalk
© 2024 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.
